Research map: Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study

Back to the article

Papers in this map

  1. “Mini-mental state” · Marshal F. Folstein · 1975 · 87558 citations · Cited by this paper
  2. Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece · 2026 · Related
  3. Effects of Intensive Glucose Lowering in Type 2 Diabetes · The Action to Control Cardiovascular Risk in Diabetes Study Group · 2008 · 7952 citations · Cited by this paper
  4. Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response · 2026 · Related
  5. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes · the ADVANCE Collaborative Group · 2008 · 7469 citations · Cited by this paper
  6. Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category · 2026 · Related
  7. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 · Kanyin Liane Ong · 2023 · 4687 citations · Cited by this paper
  8. Insulin Injection Behaviors and Association with Glycemic Outcomes in Patients with Diabetes: A Real-World Survey in Spain · 2026 · Related
  9. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range · Tadej Battelino · 2019 · 4018 citations · Cited by this paper
  10. Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review · 2026 · Related
  11. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) · Melanie J. Davies · 2022 · 2106 citations · Cited by this paper
  12. A Retrospective Analysis of the Clinical Characteristics and Treatment Patterns Among Individuals with Diabetes Receiving Insulin Therapy in Japan: The Insulin JP2DB Study · 2026 · Related
  13. Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia · The ORIGIN Trial Investigators · 2012 · 1641 citations · Cited by this paper
  14. Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment · 2026 · Related
  15. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial · Faramarz Ismail‐Beigi · 2010 · 1433 citations · Cited by this paper
  16. Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes · 2026 · Related
  17. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting · W. Todd Cade · 2008 · 1093 citations · Cited by this paper
  18. Continuous Glucose Monitoring Before and After Simultaneous Pancreas–Kidney Transplantation: Insights from a Real-World Clinical Setting · 2026 · Related
  19. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement · Tadej Battelino · 2022 · 815 citations · Cited by this paper
  20. Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG · 2026 · Related
  21. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes · International Hypoglycaemia Study Group · 2016 · 603 citations · Cited by this paper
  22. Fear of Hypoglycemia: Quantification, Validation, and Utilization · Daniel J. Cox · 1987 · 586 citations · Cited by this paper
  23. Epidemiology of severe hypoglycemia in the diabetes control and complications trial · 1991 · 483 citations · Cited by this paper
  24. The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus · W. Timothy Garvey · 1985 · 474 citations · Cited by this paper
  25. Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities · Velandai K. Srikanth · 2020 · 467 citations · Cited by this paper
  26. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 415 citations · Cited by this paper
  27. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange · Gina Agiostratidou · 2017 · 399 citations · Cited by this paper
  28. Standards of Medical Care for Patients With Diabetes Mellitus · American Diabetes Association · 2002 · 264 citations · Cited by this paper
  29. Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes · Robert A. Ritzel · 2015 · 237 citations · Cited by this paper
  30. Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes · Carol Wysham · 2017 · 222 citations · Cited by this paper
  31. Insulin glargine · Geremia B. Bolli · 2000 · 181 citations · Cited by this paper
  32. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention · Afif Nakhleh · 2021 · 160 citations · Cited by this paper
  33. Glycemic variability and cardiovascular disease in patients with type 2 diabetes · M. Rodriguez Martinez · 2021 · 157 citations · Cited by this paper
  34. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study · Gemma Rojo‐Martínez · 2020 · 154 citations · Cited by this paper
  35. Neuronal damage and cognitive impairment associated with hypoglycemia: An integrated view · Gabriela Languren · 2013 · 136 citations · Cited by this paper
  36. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates · Herbert Franz Jelinek · 2017 · 126 citations · Cited by this paper
  37. Mini-review: Impact of recurrent hypoglycemia on cognitive and brain function · Ewan C. McNay · 2010 · 111 citations · Cited by this paper
  38. One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension · Matthew C. Riddle · 2015 · 110 citations · Cited by this paper
  39. Identifying and meeting the challenges of insulin therapy in type 2 diabetes · CHRISTOPHER H. SORLI · 2014 · 88 citations · Cited by this paper

Source: OpenAlex (CC0)